date:Jul 29, 2014
tated to adjust for Svetol and krill toll manufacturing sales, first-half revenue was up 2.8% at constant exchange rates. The company noted that 2013 was marked by strong sales from Svetol in the 1st half in response to extensive media coverage and Toll Manufacturing sales including krill extraction sales for AKER BioMarine that were very robust in the 1st quarter. The major portion of krill extraction activity for AKER BioMarine, recognised under Toll Manufacturing will be transferred outside t